TFF PHARMACEUTICALS, INC. Dilutive Share Adjustment
TFF PHARMACEUTICALS, INC. reported Dilutive Share Adjustment of 25.45 million shares for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2022-11-14
- TFF PHARMACEUTICALS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2022-09-30 was 25.45M shares, a 0.31% increase year-over-year.
- TFF PHARMACEUTICALS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2022-06-30 was 25.37M shares, a 0.02% increase year-over-year.
- TFF PHARMACEUTICALS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2021-09-30 was 25.37M shares.
- TFF PHARMACEUTICALS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2021-06-30 was 25.37M shares.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month |
|---|---|---|---|
| 2022-09-30 | 25.45M shares 10-Q · filed 2022-11-14 | 25.41M shares derived: average of 2 quarters · filed 2022-11-14 | 25.40M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 25.37M shares 10-Q · filed 2022-08-11 | 25.37M shares 10-Q · filed 2022-08-11 | |
| 2021-09-30 | 25.37M shares 10-Q · filed 2022-11-14 | 25.37M shares derived: average of 2 quarters · filed 2022-11-14 | 24.64M shares 10-Q · filed 2022-11-14 |
| 2021-06-30 | 25.37M shares 10-Q · filed 2022-08-11 | 24.26M shares 10-Q · filed 2022-08-11 |